Tsingke Biotech
Beijing
About Tsingke Biotech
Tsingke Biotechnology specializes in the research and development of synthetic genomics and biosynthetic products. Its business scope covers three major directions: synthetic genomics products and services, life science research equipment and raw materials, and biomanufacturing CRO/CDMO.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1,001 – 5,000
- Total funding: $88.9M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2022)
- Website: tsingke.com
- Phone: 400-668-3730
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/tsingke-biotech-26051 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.